Organized colorectal cancer screening in Serbia – The first round within 2013–2014

  • Dušica S. Banković Lazarević Institute of Public Health of Serbia “Dr Milan Jovanović Batut”, Belgrade, Serbia
  • Zoran Krivokapić First Surgical Clinic, Clinical Center of Serbia, Belgrade, Serbia
  • Goran Barišić First Surgical Clinic, Clinical Center of Serbia, Belgrade, Serbia
  • Verica Jovanović Institute of Public Health of Serbia “Dr Milan Jovanović Batut”, Belgrade, Serbia
  • Dragan Ilić Institute of Public Health of Serbia “Dr Milan Jovanović Batut”, Belgrade, Serbia
  • Marko Veljković Institute of Public Health of Serbia “Dr Milan Jovanović Batut”, Belgrade, Serbia
Keywords: colorectal neoplasms, serbia, mass screening, diagnosis, occult blood, predictive value of tests, colonoscopy, adenoma.,

Abstract


Background/Aim. The National Organized Colorectal Cancer Screening Program was conducted in the Republic of Serbia during 2013–2014 covering the population of both genders, aged 50 to 74 years, in 28 municipalities out of 180, with the target population of 651,445 people. This organized colorectal cancer screening aim is to reduce mortality from colorectal cancer in the target population. The aim of this study was to show the results of organized screening for colorectal cancer during the first biannual round in Serbia. Methods. General practitioners from the primary health centers, invited target population by mail and by phone to perform immunochemical fecal occult blood test. Persons with a positive test results were referred to the colonoscopy. The database of health insurance and other citizens of the target population was used for invitation for screening in primary health centers. Descriptive statistical analysis of the results in organized colorectal cancer screening in the first round was performed for the key screening indicators. Results. In the first round a total of 99,592 persons were invited. The participation rate was 62.5%. Colonoscopy was performed in 1,554 persons. Adenomas were found in 586 persons (0.9% of all the tested), e.g. 37.7 % of all colonoscopied. In 129 persons colorectal cancer was diagnosed (0.2% of all the tested), e.g. 8.3% of all the colonoscopied. In the left half of the colon (rectum, sigmoid and descending colon) there were 70.4% diagnosed polyps and 77.3% carcinomas, while 29.6% of polyps and 22.7% carcinomas were found in the proximal parts of the colon. Conclusion. In the first round of the organized colorectal cancer screening in Serbia the participation rate of the targeted population was high and gave encouraging result. It was expected that in the forthcoming rounds even higher coverage of the target population would be accomplished. A positive predictive value of the completed colonoscopies showed that further observing the stages of diagnosed adenomas and carcinomas would reach the goals of the expected improvement in early detection of colorectal cancer in Serbia.

 

 


References

Bastos J, Peleteiro B, Gouveia J, Coleman MP, Lunet N. The state of the art of cancer control in 30 European countries in 2008. Int J Cancer 2010; 126(11): 2700−15.

Altobelli E, Lattanzi A, Paduano R, Varassi G, di Orio F. Colo-rectal cancer prevention in Europe: Burden of disease and sta-tus of screening programs. Prev Med 2014; 62: 132−41.

Institute of Public Health of Serbia “Dr Milan Jovanovic Ba-tut”. Cancer incidence and mortality in central Serbia 2012. In: Cancer registry of central Serbia. Report. Belgrade: Institute of Public Health of Serbia “Dr Milan Jovanovic Batut”; 2012.

von Karsa L, Patnick J, Segnan N. European guidelines for quality assurance in colorectal cancer screening and diagnosis. 1st ed.Executive summary. Endoscopy 2012; 44 Suppl 3: SE1−8.

Regulation on the National Programe on early detection of co-lorectal cancer. “Official Gazette of RS” 2013/73. (Serbian)

Levin TR, Jamieson L, Burley DA, Reyes J, Oehrli M, Caldwell C. Organized Colorectal Cancer Screening in Integrated Health Care Systems. Epidemiol Rev 2011; 33(1): 101−10.

Blom J, Kilpelainen S, Hultcrantz R, Tornberg S. Five-year expe-rience of organized colorectal cancer screening in a Swedish population - increased compliance with age, female gender, and subsequent screening round. J Med Screen 2014; 21(3): 144−50.

Guy GP, Richardson LC, Pignone MP, Plescia M. Costs and bene-fits of an organized fecal immunochemical test-based colorec-tal cancer screening program in the United States. Cancer 2014; 120(15): 2308−15.

Rabeneck L, Tinmouth JM, Paszat LF, Baxter NN, Marrett LD, Ruco A, et al. Ontario's ColonCancerCheck: results from cana-da's first province-wide colorectal cancer screening program. Cancer Epidemiol Biomarkers Prev 2014; 23(3): 508−15.

Stock C, Holleczek B, Hoffmeister M, Stolz T, Stegmaier C, Brenner H. Adherence to Physician Recommendations for Surveillance in Opportunistic Colorectal Cancer Screening: The Necessity of Organized Surveillance. PLoS One 2013; 8(12): e82676.

Charters TJ, Strumpf EC, Sewitch MJ. Effectiveness of an orga-nized colorectal cancer screening program on increasing adhe-rence in asymptomatic average-risk Canadians. BMC Health Serv Res 2013; 13(1): 449.

Spayne M, Rabeneck L, Guerriero L. Successes and Challenges in Population-Based Cancer Screening. Healthc Q 2014; 17(SP): 16−22.

McNamara D, Qasim A, Lee N, Condon C, O'Morain C. Round one of the Adelaide and Meath Hospital/Trinity College Colo-rectal Cancer Screening Programme: programme report and analysis based on established international key performance indices. Ir J Med Sci 2011; 180(2): 549−52.

Leuraud K, Jezewski-Serra D, Viguier J, Salines E. Colorectal can-cer screening by guaiac faecal occult blood test in France: Evaluation of the programme two years after launching. Can-cer Epidemiol 2013; 37(6): 959−67.

Faivre J, Hamza S. Organised screening for colorectal cancer: current position and futureprospects. Oncologie 2010; 12(10): 579−83.

Choi KS, Lee H, Jun JK, Shin A, Park E. Adherence to follow-up after a positive fecal occult blood test in an organized colo-rectal cancer screening program in Korea, 2004-2008. J Ga-stroenterol Hepatol 2012; 27(6): 1070−7.

Katičić M, Antoljak N, Kujundžić M, Stamenić V, Skoko Poljak D, Kramarić D, et al. Results of National Colorectal Cancer Screening Program in Croatia (2007-2011). World J Gastroen-terol 2012; 18(32): 4300−7.

Benson VS, Atkin WS, Green J, Nadel MR, Patnick J, Smith RA, et al. Toward standardizing and reporting colorectal cancer screening indicators on an international level: The international colorectal cancer screening network. Int J Cancer 2011; 130(12): 2961−73.

Segnan N, Senore C, Andreoni B, Azzoni A, Bisanti L, Cardelli A, et al. Comparing Attendance and Detection Rate of Colonos-copy With Sigmoidoscopy and FIT for Colorectal Cancer Screening. Gastroenterology 2007; 132(7): 2304−12.

Major D, Bryant H, Delaney M, Fekete S, Gentile L, Harrison M, et al. Colorectal cancer screening in Canada: results from the first round of screening for five provincial programs. Curr Oncol 2013; 20(5): 252−7.

Logan RF, Patnick J, Nickerson C, Coleman L, Rutter MD, von Wagner C. Outcomes of the Bowel Cancer Screening Pro-gramme (BCSP) in England after the first 1 million tests. Gut 2012; 61(10): 1439−46.

Published
2017/02/01
Section
Original Paper